The investigators reported that treatment with darolutamide reduced the risk of radiological progression or death by 49% in ...

Panelist discusses how benign prostatic hyperplasia (BPH) and its treatments impact men’s sexual health, emphasizing the importance of balancing symptom relief with sexual function preservation, and ...

Urologists discuss innovative BPH treatments, emphasizing personalized care, and the importance of ejaculatory preservation. Welcome back to Pearls & Perspectives! In this episode of Pearls & ...

The AUA Advocacy Summit covers diverse topics, including Medicare reform, workforce challenges, and state-level issues, appealing to a broad urology audience. A virtual poster session allowed trainees ...

The Hugo robotic surgical platform showed high efficacy with a 98.5% surgical success rate, exceeding the 85% performance goal. Safety was confirmed with low rates of grade 3 or higher Clavien-Dindo ...

“I think the best thing about these guidelines is their actual existence,” says Karyn S. Eilber, MD. One of many notable highlights from the 2025 American Urological Association Annual Meeting in Las ...

Vibegron treatment in men with OAB and BPH showed positive long-term safety and efficacy over 52 weeks. The extension trial involved 276 participants, with 90.6% completing the study. Adverse events ...

Corinna Hughes, DNP, sits down with Amy Pearlman, MD, to discuss the evolving recognition of APPs in urology. Welcome back to Pearls & Perspectives! In this edition of Pearls & Perspectives from the ...

In a recent interview with Urology Times®, endourologist Perry Xu, MD, was asked about how he goes about shared decision-making in his practice. “Coupled with all of these innovations, there are also ...

"To me, the key take-home is that the benefits that we see in clinical trials, we actually can replicate in the real world," says Stephen J. Freedland, MD. Findings from a review of randomized ...

Kevin C. Zorn, MD, FRCSC, FACS, recaps the AUA 2025 session, “State-of-the-Art Lecture: Preservation of Ejaculatory Function with BPH Treatments." Preservation of ejaculatory function is a top ...

“It is likely that more and more, these newer agents are going to play earlier and more central roles in the early treatment of BCG-unresponsive disease," says Shreyas S. Joshi, MD, MPH. He explained, ...